A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women

Clinical trial NCT02337387 · TERMINATED

Trial details

NCT number: NCT02337387
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2015-01-01
Primary completion: 2015-03-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.